Tingling and similar feelings were reported in 8.8% of the 9 mg group and 20.9% of the 12 mg group, compared with 0.7% on placebo
What the published record does establish clearly is the result: studies appear to have been cancelled or stopped without any published conclusions, leaving a compound with over three decades of preclinical research and almost no completed human trial data [10]
Author Contributions Ping Feng, Xiaoyan Sheng, Yongjia Ji, Shweta Urva, Feng Wang, Sheila Miller, Chenxi Qian, Zhenmei An, and Yimin Cui provided substantial contributions to the conception and design, acquisition of data, or analysis and interpretation of data
While Ozempic mimics one hunger-relieving hormone, and Mounjaro mimics two, Eli Lilly is working on what's called a "triple agonist," with three different hormone-like substances inside